Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational study

Matthieu Petit,Frank Bidar,Quentin Fosse,Lucie Lefevre,Marine Paul,Tomas Urbina,Paul Masi,Florent Bavozet,Jérémie Lemarié,Etienne de Montmollin,Chloé Andriamifidy-Berti,Julien Dessajan,Benjamin Zuber,Lara Zafrani,Edwige Peju,Paris Meng,Liliane Charrier,Loic Le Guennec,Marie Simon,Charles-Edouard Luyt,Luc Haudebourg,Guillaume Geri
DOI: https://doi.org/10.1186/s13054-024-04820-7
IF: 15.1
2024-02-07
Critical Care
Abstract:Ventilator associated pneumonia (VAP) due to wild-type AmpC-producing Enterobacterales (wtAE) is frequent in intensive care unit (ICU) patients. Despite a low level of evidence, definitive antimicrobial therapy (AMT) with third generation cephalosporins (3GCs) or piperacillin is discouraged.
critical care medicine
What problem does this paper attempt to address?